Sponsors – 2023 Mexico-USA Exposome Symposium

The Mount Sinai Institute for Exposomic Research is the nucleus of the Icahn School of Medicine’s work on studying how the environment affects human health. Our mission is to understand how the exposome, or the totality of our environmental exposures, affect health, disease, and development. We aim to translate our findings into new strategies for prevention and treatment.

The National Institute of Public Health (Instituto Nacional de Salud Pública, or INSP), is a leading institution in teaching, research and service to improve public health in Mexico and Latin America. INSP is committed to fostering collaborations with other research institutions, government agencies, and international organizations to advance the field of public health. Its work has had a significant impact on public health policies and programs in Mexico and beyond, and its research has contributed to the development of best practices in public health around the world.

The National Autonomous University of Mexico (Universidad Nacional Autónoma de México), also known as UNAM, is one of the most prestigious and well-respected universities in Latin America. UNAM is committed to promoting social justice, environmental sustainability, and cultural diversity, and its research and outreach efforts have had a significant impact on Mexican society and beyond.

The Institute of Biomedical Research (El Instituto de Investigaciones Biomédicas) is dedicated to conducting cutting-edge research in the field of biomedical sciences, with a focus on the development of new diagnostic and therapeutic tools for a variety of diseases.

LinusBio is a patient-centric, precision exposome medicine company headquartered in New York, NY.  Originating from the world’s leading exposome laboratory at the Icahn School of Medicine at Mount Sinai, Linus has developed a technology platform that builds on breakthroughs in exposome sequencing.

The Programming Research in Obesity, Growth, Environment and Social Stressors (PROGRESS) study is a collaboration between Icahn School of Medicine at Mount Sinai, Harvard University and the National Institute of Public Health (INSP) in Mexico. PROGRESS uses state-of-the-art methods in social science, epidemiology, and toxicology to assess transdisciplinary risk factors impacting neurodevelopment. PROGRESS may be the first birth cohort specifically designed to prospectively address the joint impact of chronic stress and toxic metals on child development. (R24ES028522, R01ES013744)

Mount Sinai Human Health Exposure Analysis
Resource (HHEAR)
Lab Hubs and Data Center

(U2CES026561, U2CES026555)

HEALS, the Mount Sinai
Health Sciences
Core Center


Mount Sinai ConduITS
Clinical and Translational
Science Award (CTSA) Program